Threshold US · Senior housing

Nursing home supply in Georgia

356 certified nursing homes · 39,494 certified beds · CMS Care Compare
356
certified nursing homes
39,494
certified beds
111
average beds per home
21,640
beds in 1 or 2-star homes (at-risk supply)

CMS rating mix

Certified beds by CMS overall 5-star rating across Georgia. Beds in 1 and 2-star homes are supply that may not survive, and therefore latent replacement demand.

5-star3,905 beds
4-star5,895 beds
3-star7,628 beds
2-star8,826 beds
1-star12,814 beds
Not rated426 beds

Largest markets by beds

CityHomesBeds
Atlanta203,127
Macon121,284
Columbus71,106
Augusta101,038
Marietta7904
Savannah7796
Decatur6753
Rome8714

Ownership

Ownership typeHomesBeds
For Profit - Limited Liability Company13415,665
For Profit - Corporation9310,018
Non Profit - Other515,122
Non Profit - Corporation404,290
For Profit - Individual141,755

Largest nursing homes

HomeCityBedsCMS rating
Crestview Health & Rehab CtrAtlanta3881-star
Riverview Health & Rehab CtrSavannah2841-star
Bostick Nursing CenterMilledgeville2801-star
Roswell Center For Nursing And Healing LlcRoswell2681-star
Baptist Village, Inc.Waycross2545-star
Pruitthealth - PalmyraAlbany2501-star
Parkside At Budd Terrace Operating Company LlcAtlanta2503-star
Douglasville Center For Nursing And Healing LlcDouglasville2461-star

The demand gap

Coming shortly: the population aged 85+ in each catchment and the demand gap against the national rate, from US Census Bureau data (being finalized). Supply above is live now from CMS. Join the waitlist to be first in when the Georgia demand analysis goes live.

Appraise any Georgia site in 60 seconds

Threshold US Care is launching in 2026. Drop a pin anywhere in Georgia: every competing certified bed and its CMS rating, the demand gap, and the maximum land bid. Reserve founding access for Georgia now.

Join the Georgia waitlist

All states → · The US senior care gap →

Supply: CMS Care Compare Provider Information (public domain), latest release. Every figure is a statistical estimate for site screening, not a USPAP appraisal or investment advice.